Achalasia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 06
SKU : PH4121
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the expected growth rate of the achalasia treatment market?
The achalasia treatment market is expected to reach a high CAGR during the forecast period (2022-2029), driven by increasing prevalence, rising awareness, and the development of new treatment options.
Who are the major players in the achalasia treatment market?
The major players in the global achalasia treatment market include Bausch Health US LLC., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc, Pfizer Inc., Accord Healthcare, AdvaCare Pharma, Merz Therapeutics, and Galderma.